Document is current
Any future updates will be listed below
-
Authors
Lv, Huimin
Sun, Tao
Ling, Xiaoling
Liu, Xinlan
Yang, Jin
Zhang, Mengwei
Niu, Limin
Chen, Shumin
Liu, Zhenzhen
Wang, Chengzheng
Sun, Huihui
Wang, Jing
Zeng, Huiai
Zhao, Shengnan
Guo, Lanwei
Feng, Yajing
Zhang, Zhiqing
Xia, Qingxin
Qiu, Rongguo
Yan, Min
-
Funding
Funding for this research was provided by:
China Scientific Research Fund for HER2 Target from the China Anti-Cancer Association (CORT-239-M14)
- License Information
-
More Information
Article History
Received: 15 October 2025
Accepted: 13 January 2026
First Online: 27 January 2026
Declarations
:
: This study was performed in accordance with the Declaration of Helsinki and Good Clinical Practice (GCP). The protocol was approved by the ethics committee of Henan Cancer Hospital (NO.2020–341-003). All participants provided written informed consent.
: Not applicable.
: The authors declare no competing interests.
